MedTrace Logo

Does Medical Cannabis Reduce Opioid Use in Adults With Pain

NCT04308148 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 217

Last updated 2024-03-25

No results posted yet for this study

Summary

The study will examine how medical cannabis use affects opioid analgesic use. This landmark study will be among the first to examine the effect of medical cannabis with different THC/CBD (Tetrahydrocannibinol/Cannabidiol) content on opioid use as well as adverse events.

Conditions

Sponsors & Collaborators

  • Laura and John Arnold Foundation

    collaborator OTHER

  • Vireo Health

    collaborator OTHER

  • Albert Einstein College of Medicine

    lead OTHER

Principal Investigators

  • Julia Arnsten, MD, MPH · Albert Einstein College of Medicine

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-06
Primary Completion
2024-03-13
Completion
2024-03-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04308148 on ClinicalTrials.gov